FlynancialAnalyst Posted - 4 days ago

$MRUS $2.64B mc $XBI name showing significant RS to biotech today with accumulation off this key $40 level and 20 wk SMA 87.36% institutionally owned. 7.18% short float, TRENDING LOWER from 15.63% just 6 months. #CoverOrPerish... wants ATHs TrendEdge.app/asset/MRUS

Following_the_trend Posted - 4 days ago

$MRUS On the move up today

Stock_Titan Posted - 5 days ago

$MRUS Merus Announces Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting https://www.stocktitan.net/news/MRUS/merus-announces-abstracts-accepted-for-presentation-at-the-2024-asco-96f4oe7eiqy0.html

Stocksrunner Posted - 1 week ago

A number of stocks across various sectors - including $CRSR $MRUS $VIPS $XNCR, and $CWH - have recently entered oversold territory based on their RSI readings. Per Warren Buffett's advice, this could signal an opportunity for contrarian investors willing to be "greedy when others are fearful." Time to dig deeper on these potentially undervalued names? 🤔

RonIsWrong Posted - 2 weeks ago

$ALPN $XBI $MRUS $SWTX $FUSN FUSN ☑️ ALPN ☑️ SNDX _?_ SWTX - bring it !! KRYS _?_

Stock_Titan Posted - 3 weeks ago

$MRUS Merus Presents Preclinical Data Demonstrating Efficacy of Zeno in Cancer Models with High NRG1 Expression at the AACR Annual Meeting 2024 https://www.stocktitan.net/news/MRUS/merus-presents-preclinical-data-demonstrating-efficacy-of-zeno-in-0qafxe9oqbfb.html

Capitulation_0 Posted - 3 weeks ago

$XBI $MRUS $ANNX and more catalyst readouts

Cardfellow007 Posted - 3 weeks ago

$MRUS Hoping to hear about LBA when announced at AACR tomorrow

Stock_Titan Posted - 3 weeks ago

$MRUS Merus to Participate in a Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference https://www.stocktitan.net/news/MRUS/merus-to-participate-in-a-fireside-chat-at-the-23rd-annual-needham-yd10qi25ajf6.html

Following_the_trend Posted - 1 month ago

$MRUS I haven't sold a share

FlynancialAnalyst Posted - 1 month ago

link share feature is lowkey one of fav features of new TrendEdge.app v 4.0.x Completely seamless, so we all see the same results $VKTX $MRUS $IMNM $FULC $SMMT

G101SPM Posted - 1 month ago

@S_Franconi per request: $MRUS $44.82 carries SPM 83.01 tag.

S_Franconi Posted - 1 month ago

@G101SPM Can you run $MRUS?

Fedex11 Posted - 1 month ago

$MRUS I find this one intriguing but I cannot buy until chart firms up

MILANOW1 Posted - 1 month ago

$MRUS Did you guys sell already ? I have small amount +130$ right now, but I believe that this is not the edge. Company looks promising, management doing well and I will wait for at least +65$. How do you think ? Am I naive ?

OpenOutcrier Posted - 1 month ago

$MRUS (+1.5% pre) Gilead Sciences $GILD, Merus (MRUS) Announce Collaboration to Discover Novel Antibody-Based Trispecific T-Cell Engagers - SI https://ooc.bz/l/27120

DonCorleone77 Posted - 1 month ago

$MRUS $GILD 2 of 2 - Merus to receive $56M upfront in deal with Gilead to discover antigens ....Merus will receive an upfront cash payment of $56M for initial targets as well as an equity investment by Gilead of $25M M in Merus common shares. Across all potential programs, Merus is also eligible to receive up to $1.5 B including additional near term and option payments, potential development and commercialization milestones, as well as tiered royalties ranging from the mid-single to low-double digits on product sales should Gilead successfully commercialize a therapy from the collaboration. For the third potential program, Merus may opt-in to share 50/50 split of net profits and net losses, in lieu of future milestone and royalty payments. Gilead does not exclude acquired IPR&D expenses from its non-GAAP financial measures. This transaction with Merus is expected to reduce Gilead's GAAP and non-GAAP 2024 EPS by approximately 3c - 5c.

DonCorleone77 Posted - 1 month ago

$MRUS $GILD 1 of 2 - Merus to receive $56M upfront in deal with Gilead to discover antigens Gilead Sciences (GILD) and Merus (MRUS) announced a research collaboration, option and license agreement to discover novel dual tumor-associated antigens TAA targeting trispecific antibodies. Gilead and Merus agreed to collaborate on the use of Merus' proprietary Triclonics platform along with Gilead's oncology expertise to research and develop multiple, separate preclinical research programs. Under the terms of the agreement, Merus will lead early-stage research activities for two programs, with an option to pursue a third. Gilead will have the right to license programs developed under the collaboration after the completion of select research activities. If Gilead exercises its option to license any such program from the collaboration, Gilead will be responsible for additional research, development and commercialization activities for such program....

Stock_Titan Posted - 1 month ago

$GILD $MRUS Gilead and Merus Announce Collaboration to Discover Novel Antibody-Based Trispecific T-Cell Engagers https://www.stocktitan.net/news/GILD/gilead-and-merus-announce-collaboration-to-discover-novel-antibody-gs0sqjgl2g5h.html

Stock_Titan Posted - 1 month ago

$MRUS Merus Announces Publication of an Abstract for Presentation at the AACR Annual Meeting 2024: Zeno is effective in cancer models with high NRG1 expression https://www.stocktitan.net/news/MRUS/merus-announces-publication-of-an-abstract-for-presentation-at-the-ruvik3ho4pyw.html

Stock_Titan Posted - 1 month ago

$MRUS Merus to Participate in a Fireside Chat at the Leerink Partners Global Biopharma Conference https://www.stocktitan.net/news/MRUS/merus-to-participate-in-a-fireside-chat-at-the-leerink-partners-sasdqwyiohi0.html

Jt11111 Posted - 1 month ago

$CTMX Partnerships, technology and products...look at $MRUS and tell me if this stock is a great deal!

Doodle1800 Posted - 1 month ago

$MRUS glad I didnt sell... nice! - wheres the ceiling? I cant predict!!!

Herrfranz Posted - 1 month ago

$MRUS added

Following_the_trend Posted - 1 month ago

$MRUS Chart still looking great

Doodle1800 Posted - 1 month ago

$MRUS 2.5k profit on 100 shares - time to sell?

NorthWestHawk Posted - 2 months ago

Attached $MRUS Financial Results for Q4 2023 Earnings and Business Update, and brief comments: As of 2023 EOY, Merus had $412M cash, cash equivalents and marketable securities, and expected to fund Merus’ operations into 2027. I'm wondering if analysts would raise their targets (?) $MRUS already rose 100% since Dec 2023, i.e. after Stifel wrote that: 1️⃣ Initial Petosemtamab + Pembrolizumab Combo 1L HNSCC data will be a large binary catalyst by 1H2024; 2️⃣ 40% of Merus’ stock price is derived from investors believing that it will be successfully developed for 1L HNSCC, even without any combo data presented to date; Stay tuned for a comparison between Merus and its competitors in treating H&N cancer patients on 1L combination with $MRK Merck's Pembrolizumab. Disclosure: I currently have No Position (NP) on $MRUS, and I do not plan to initiate one in the near future. #StockMarket #biotech #pharmaceutical https://ir.merus.nl/news-releases/news-release-details/merus-announces-financial-results-fourth-quarter-and-full-year-3

epsguid Posted - 2 months ago

$MRUS reported a loss of $1.09, consensus was ($0.71) via @eWhispers #epsmiss http://eps.sh/d/mrus

Stock_Titan Posted - 2 months ago

$MRUS Merus Announces Financial Results for the Fourth Quarter and Full Year 2023 and Provides Business Update https://www.stocktitan.net/news/MRUS/merus-announces-financial-results-for-the-fourth-quarter-and-full-xpwlj1syooub.html